Financial Insights

Sun Pharmaceutical Industries

The company is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback’s molnupiravir under the brand name Molxvir in India.

The Drugs Controller General of India is currently reviewing clinical data of molnupiravir for the treatment of COVID-19 in adults in India.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button